SMARCA4 and central nervous system cancer: We demonstrate that a PROTAC tool compound AU-15330 that simultaneously degrades the ATPases SMARCA4 and SMARCA2 and PBRM1 selectively kills H3.3K27M but not H3WT glioma cell lines.